Aug. 12, 2013 — An increasing focus on the healthcare consumer’s needs and preferences may play a role in future industry product development priorities. According to a recent health survey commissioned the Pharmaceutical Research and Manufacturers of America (PhRMA), 86 percent of Americans believe that developing cures for more forms of cancer should be one of the top national health priorities, followed by effective treatment for heart disease (78 percent) and more intensive medical care for seniors (76 percent).
The PhRMA survey, “From Hope to Cures: PhRMA’s First Annual Health Survey,” was conducted by Hart Research Associates and “explores Americans’ attitudes on personal health and medical concerns.” This survey and the FDA’s ongoing initiatives to engage patients in dialogues about particular conditions and therapies – as well as clinical trials – demonstrate the growing role that consumers play in their own healthcare.
“Clearly, the PhRMA research demonstrates once again that patient communication and engagement is key to better health outcomes,” said Coalition for Healthcare Communication Executive Director John Kamp. “Indeed, public policy makers must begin to understand that medical communication by medicine companies plays a major part in the safe and effective use of medications.”
John J. Castellani, president and CEO of PhRMA, said in a statement that a patient-centric dialogue “is crucial to improving health outcomes,” and that the survey findings will help “inform efforts to address major health challenges such as chronic disease, improved prevention and wellness activities and enhanced patient adherence to prescribed therapies.”
Other consumer concerns listed in the survey findings are obesity, diet and weight management. For additional coverage of the survey, go to Medivo’s BTP Insights at: